Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +54.01%
#3 Glidr Glidr +41.01%
#4 Cysic Cysic +38.33%
#5 Walrus Walrus +27.54%
#6 Humanity Humanity +25.25%
#7 Enso Enso +17.24%
#8 Tutorial Tutorial +15.94%
#9 The Black Bull The Black Bull +14.95%
#10 Codatta Codatta +14.84%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Rank in Stocks #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Share Price
$0.069
Last synced: 2024-07-22
Market Cap
$2.06M
Change (1 day)
-1.43%
Change (1 year)
0.00%
Country
US
Trade DermTech, Inc. (DMTK)

Category

Healthcare
Number of shares outstanding for DermTech, Inc. (DMTK)
Number of shares outstanding as of March 2024: 34.71M
According to DermTech, Inc. latest financial reports and stock price the company's current number of shares outstanding is 34.71M. At the end of December 2022 the company had 30.04M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for DermTech, Inc. (DMTK) from 2012 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 34.71M 6.33%
2023 32.64M 8.66%
2022 30.04M 4.00%
2021 28.89M 70.12%
2020 16.98M 142.38%
2019 7.01M 196.70%
2018 2.36M 29.52%
2017 1.82M -61.36%
2013 4.72M 37.11%
2012 3.44M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 371.00M 968.98%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 705.30M 1,932.21%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 143.28M 312.84%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 80.10M 130.78%
US